Cross-resistance associated with development resistance to isometamidium in a clone of Trypanosoma congolense

Resistance to isometamidium was increased 94-fold in a clone of Trypanosoma congolense (clone IL 1180) by repeated subcurative treatment of infected mice for 11 months. This was associated with 3.4-, 33-, and 4.2-fold increases in resistance to diminazene, homidium, and quinapyramine, respectively....

Full description

Bibliographic Details
Main Authors: Peregrine, A.S., Gray, M.A., Moloo, S.K.
Format: Journal Article
Language:Inglés
Published: 1997
Subjects:
Online Access:https://hdl.handle.net/10568/30084
_version_ 1855540251692367872
author Peregrine, A.S.
Gray, M.A.
Moloo, S.K.
author_browse Gray, M.A.
Moloo, S.K.
Peregrine, A.S.
author_facet Peregrine, A.S.
Gray, M.A.
Moloo, S.K.
author_sort Peregrine, A.S.
collection Repository of Agricultural Research Outputs (CGSpace)
description Resistance to isometamidium was increased 94-fold in a clone of Trypanosoma congolense (clone IL 1180) by repeated subcurative treatment of infected mice for 11 months. This was associated with 3.4-, 33-, and 4.2-fold increases in resistance to diminazene, homidium, and quinapyramine, respectively. Both T. congolense IL 1180 and the resistant derivative were able to undergo cyclical development in Glossina morsitans centralis tsetse flies, producing hypopharyngeal infection rates of 40.0 and 39.8 percent, respectively.
format Journal Article
id CGSpace30084
institution CGIAR Consortium
language Inglés
publishDate 1997
publishDateRange 1997
publishDateSort 1997
record_format dspace
spelling CGSpace300842022-01-29T16:17:57Z Cross-resistance associated with development resistance to isometamidium in a clone of Trypanosoma congolense Peregrine, A.S. Gray, M.A. Moloo, S.K. trypanosoma congolense drugs resistance to chemicals Resistance to isometamidium was increased 94-fold in a clone of Trypanosoma congolense (clone IL 1180) by repeated subcurative treatment of infected mice for 11 months. This was associated with 3.4-, 33-, and 4.2-fold increases in resistance to diminazene, homidium, and quinapyramine, respectively. Both T. congolense IL 1180 and the resistant derivative were able to undergo cyclical development in Glossina morsitans centralis tsetse flies, producing hypopharyngeal infection rates of 40.0 and 39.8 percent, respectively. 1997 2013-06-11T09:26:09Z 2013-06-11T09:26:09Z Journal Article https://hdl.handle.net/10568/30084 en Open Access Antimicrobial Agents and Chemotherapy;41(7): 1604-1606
spellingShingle trypanosoma congolense
drugs
resistance to chemicals
Peregrine, A.S.
Gray, M.A.
Moloo, S.K.
Cross-resistance associated with development resistance to isometamidium in a clone of Trypanosoma congolense
title Cross-resistance associated with development resistance to isometamidium in a clone of Trypanosoma congolense
title_full Cross-resistance associated with development resistance to isometamidium in a clone of Trypanosoma congolense
title_fullStr Cross-resistance associated with development resistance to isometamidium in a clone of Trypanosoma congolense
title_full_unstemmed Cross-resistance associated with development resistance to isometamidium in a clone of Trypanosoma congolense
title_short Cross-resistance associated with development resistance to isometamidium in a clone of Trypanosoma congolense
title_sort cross resistance associated with development resistance to isometamidium in a clone of trypanosoma congolense
topic trypanosoma congolense
drugs
resistance to chemicals
url https://hdl.handle.net/10568/30084
work_keys_str_mv AT peregrineas crossresistanceassociatedwithdevelopmentresistancetoisometamidiuminacloneoftrypanosomacongolense
AT grayma crossresistanceassociatedwithdevelopmentresistancetoisometamidiuminacloneoftrypanosomacongolense
AT moloosk crossresistanceassociatedwithdevelopmentresistancetoisometamidiuminacloneoftrypanosomacongolense